Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOTS-c in Adults With Prediabetes and Overweight/Obesity
NCT07505745Phase 2Recruiting
- Sponsor
- Hudson Biotech
- Start
- Feb 2026
- Primary completion
- Feb 2027
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MOTS-c in prediabetes, insulin resistance (IR), sponsored by Hudson Biotech. Started Feb 2026; status: recruiting.
02
Drugs
MOTS-c
03
Conditions
prediabetesinsulin resistance (IR)
Beyond the preview
Go deeper on NCT07505745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07505745.